Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $198 | In Stock | |
5 mg | $538 | In Stock | |
10 mg | $863 | In Stock | |
25 mg | $1,290 | In Stock | |
50 mg | $1,760 | In Stock | |
100 mg | $2,380 | In Stock |
Description | Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research. |
Alias | FPA144 |
Molecular Weight | 144 kDa |
Cas No. | 1952272-74-0 |
Storage | store at low temperature | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.